Device Trial Radar · NCT03147313
Extracorporal Shock Wave Treatment to Improve Nerve Regeneration
Last checked: Nov 19, 2026Latest source record: Sep 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Apr 18, 2017
Primary completion
Apr 2023
Study completion Jun 2023
Sponsor
- Lead sponsor
- Ludwig Boltzmann GesellschaftAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 10, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves. Participants will be randomized into two treatment groups with different settings and a sham group. The participants will thereafter followed-up in a prospective, double-blind study design.
Conditions
- Peripheral Nerve Injury
Interventions
MTS Medical UG Orthogold 100Device
300 or 500 pulses, frequency 3Hz, energy 1 (0,1mJ/mm2)
ShamDevice
Extracorporeal shock wave treatment will be faked.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Two Point DiscriminationTime frame: 1 year
- Semmes Weinstein Monofilament testTime frame: 1 year
- Pain/DiscomfortTime frame: 1 year
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Meidling Trauma Hospital
Vienna, Austria · Recruiting
Lorenz Böhler Trauma Hospital
Vienna, Austria · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.